Literature DB >> 9036362

[Involvement of the central nervous system in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura].

D Ohlmann1, G F Hamann, M Hassler, K Schimrigk.   

Abstract

Cerebral involvement is typical for thrombotic microangiopathies like haemolytic uremic syndrome (HUS) and thrombotic-thrombopenic purpura (Moschcowitz disease or TTP). Symptoms are irritation, restless behaviour, disorientation, disturbance of consciousness, seizures, and focal neurological deficits. The lack of typical imaging changes or pathological observations may explain the unknown pathophysiological cascade leading to the neurological symptoms. We describe the development of HUS/ TTP in a 52-year-old woman after acute pneumonia caused by Diplococcus pneumoniae. The patient showed an increasing psycho-organic syndrome with disorientation, followed by severe loss of consciousness and coma. Initially, computed tomography showed slight diffuse brain oedema, which was not found in later follow-up images. Magnetic resonance imaging was normal. The TCD examination revealed general velocity increases and vasospasms (especially MCA, ACA and PCA bilateral and BA). The reduction in blood flow velocities in the basal arteries was accompanied by a marked clinical improvement. The development of vasospasms may be an explanation for the neurological deficits in HUS/TTP. The origin of the vasospasms may be found in disturbed prostacyclin production, increased serotonin or platelet factor IV release, and leucocyte activation with consecutive endothelial damage.

Entities:  

Mesh:

Year:  1996        PMID: 9036362     DOI: 10.1007/s001150050066

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  7 in total

1.  Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin.

Authors:  P B Eisenhauer; P Chaturvedi; R E Fine; A J Ritchie; J S Pober; T G Cleary; D S Newburg
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

3.  Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI.

Authors:  Karin Weissenborn; Eva Bültmann; Frank Donnerstag; Anja M Giesemann; Friedrich Götz; Hans Worthmann; Meike Heeren; Jan Kielstein; Anke Schwarz; Heinrich Lanfermann; Xiao-Qi Ding
Journal:  Neuroradiology       Date:  2013-04-05       Impact factor: 2.804

4.  [Thrombotic thrombocytopenic purpura. Reduced activity of von Willebrand factor cleaving protease].

Authors:  A Kunze; C Terborg; J Gerth; G Heide; O W Witte
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

5.  A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.

Authors:  Paolo Giordano; Giuseppe Stefano Netti; Luisa Santangelo; Giuseppe Castellano; Vincenza Carbone; Diletta Domenica Torres; Marida Martino; Michela Sesta; Franca Di Cuonzo; Maria Chiara Resta; Alberto Gaeta; Leonardo Milella; Maria Chironna; Cinzia Germinario; Gaia Scavia; Loreto Gesualdo; Mario Giordano
Journal:  Pediatr Nephrol       Date:  2018-10-25       Impact factor: 3.714

6.  Pneumococcal hemolytic uremic syndrome and steroid resistant nephrotic syndrome.

Authors:  Andrew P Groves; Patrick Reich; Binayak Sigdel; T Keefe Davis
Journal:  Clin Kidney J       Date:  2016-05-04

7.  Frequency of neurological involvement in patients with/without diarrhea hemolytic uremic syndrome: A Systematic review and meta-analysis.

Authors:  Azita Tavasoli; Nazanin Zafaranloo; Rozita Hoseini; Hasan Otukesh; Shahrbanoo Nakhaiee
Journal:  Med J Islam Repub Iran       Date:  2021-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.